Kilmarnock

This trial is comparing ibrutinib with, and without, treatment breaks. It is for people that have had ibrutinib for chronic lymphocytic leukaemia before.

This study is looking at using small pieces of the DNA of bowel cancer that circulate in the blood (ctDNA) to work out whether the cancer might come back.

This trial is comparing a combination of 2 chemotherapy drugs with a combination of 3 chemotherapy drugs for bowel cancer.

This trial is looking at chemotherapy before surgery for bowel cancer to improve treatment.

This trial is looking at biomarkers to see if more people could benefit from cetuximab and panitumumab.

This trial is looking at durvalumab with standard treatment to shrink cancer of the back passage (rectal cancer) before having surgery to remove it.

This trial is looking at the need to treat the lymph glands in the armpit after having chemotherapy followed by surgery for breast cancer.

This study is for people recently diagnosed with certain cancers who are waiting to have treatment.

This trial is comparing olaparib and chemotherapy to chemotherapy alone for triple negative breast cancer or breast cancer with a change in the BRCA gene.

This study is looking at biomarkers in tissue and blood samples of people with Hodgkin lymphoma to help tell how well the treatment is working.